Back to Results
First PageMeta Content
Pharmacology / European Federation of Pharmaceutical Industries and Associations / Novartis / Boehringer Ingelheim / Bayer Schering Pharma / Innovative Medicines Initiative / Biomarker / Sanofi / Bayer / Medicine / Pharmaceutical industry / Pharmaceutical sciences


IMI 1ST CALL PROJECTS: SAFETY SAFE-T SAFER AND FASTER EVIDENCE-BASED TRANSLATION SUMMARY:
Add to Reading List

Document Date: 2011-04-01 08:57:16


Open Document

File Size: 88,76 KB

Share Result on Facebook

City

Brentford / Berlin / Basingstoke / BARCELONA / Sandwich / Ingelheim / Tel Aviv / Södertälje / Bruxelles / Basel / Reutlingen / Paris / /

Company

GlaxoSmithKline / Aventis / Novartis Pharma AG / Boehringer Ingelheim International GmbH / Sanofi / Amgen / AstraZeneca AB / F. Hoffmann-La Roche AG / Eli Lilly And Company Limited / Development LTD / Bayer Schering Pharma AG / Pfizer Limited / Laboratorios Almirall S.A. / /

Continent

Europe / /

Country

Switzerland / Germany / Belgium / France / United States / United Kingdom / Sweden / Spain / /

IndustryTerm

improved tools / pharmaceutical / /

MedicalCondition

drug-induced injuries / specific organ injury / different disease / /

Organization

Foundation For Medical Research Infrastructural Development And Health Services / Universität Tübingen / Medizinisches Institut / Consorci Institut Català de Ciències Cardiovasculars / /

Position

Scientific coordinator / Coordinator / /

Technology

drug development / /

SocialTag